Jonas Ristau

662 total citations
19 papers, 359 citations indexed

About

Jonas Ristau is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Jonas Ristau has authored 19 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 5 papers in Surgery. Recurrent topics in Jonas Ristau's work include Advanced Radiotherapy Techniques (10 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Jonas Ristau is often cited by papers focused on Advanced Radiotherapy Techniques (10 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Jonas Ristau collaborates with scholars based in Germany, United States and Switzerland. Jonas Ristau's co-authors include Jürgen Debus, Stefan A. Koerber, Fabian Weykamp, Klaus Herfarth, Frederik L. Giesel, Juliane Hörner‐Rieber, Sebastian Klüter, Sebastian Adeberg, Michael Thomas and Clemens Kratochwil and has published in prestigious journals such as International Journal of Cancer, Radiotherapy and Oncology and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

Jonas Ristau

18 papers receiving 358 citations

Peers

Countries citing papers authored by Jonas Ristau

Since Specialization

Citations

This map shows the geographic impact of Jonas Ristau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Ristau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Ristau more than expected).

Fields of papers citing papers by Jonas Ristau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Ristau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Ristau. The network helps show where Jonas Ristau may publish in the future.

Co-authorship network of co-authors of Jonas Ristau

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Ristau. A scholar is included among the top collaborators of Jonas Ristau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Ristau. Jonas Ristau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer 2025 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), (unknown), Fabian Weykamp, Jonas Ristau, (unknown), (unknown), Eva Meixner, (unknown), Eric Tonndorf‐Martini, K Schubert, Charles C. Steidel, L. Wessel, Jürgen Debus, Jakob Liermann	1
2	Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer 2024 ·Frontiers in Oncology ·(unknown), (unknown), Lukas Baumann, Jakob Liermann, Philipp Hoegen, Jonas Ristau, Sebastian Regnery, (unknown), Laila König, (unknown), David Bonekamp, Heinz‐Peter Schlemmer, Jürgen Debus, Stefan A. Koerber, Sebastian Klüter, Juliane Hörner‐Rieber	6
3	MR-linac based radiation therapy in gastrointestinal cancers: a narrative review 2024 ·Journal of Gastrointestinal Oncology ·Jonas Ristau, Juliane Hörner‐Rieber, (unknown)	0
4	A body mass index-based method for “MR-only” abdominal MR-guided adaptive radiotherapy 2023 ·Zeitschrift für Medizinische Physik ·(unknown), (unknown), (unknown), (unknown), (unknown), Juliane Hörner‐Rieber, Jonas Ristau, Jürgen Debus, M. Alber, Sebastian Klüter	3
5	Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk 2022 ·Clinical and Translational Radiation Oncology ·Philipp Hoegen, (unknown), (unknown), Sebastian Regnery, Fabian Weykamp, (unknown), Jonas Ristau, Jakob Liermann, Eva Meixner, Tobias Förster, (unknown), (unknown), (unknown), Jürgen Debus, Sebastian Klüter, Juliane Hörner‐Rieber	11
6	Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial 2022 ·Radiation Oncology ·Jonas Ristau, Juliane Hörner‐Rieber, (unknown), Sebastian Klüter, (unknown), Lukas Baumann, Nicolaus Andratschke, Helena Garcia Schüler, Matthias Gückenberger, (unknown), Maximilian Niyazi, Claus Belka, Klaus Herfarth, Jürgen Debus, Stefan A. Koerber	11
7	Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3) 2022 ·Radiation Oncology ·Sebastian Regnery, Jonas Ristau, Fabian Weykamp, Philipp Hoegen, (unknown), (unknown), (unknown), Sebastian Klüter, (unknown), (unknown), (unknown), Jan Meis, Thomas Welzel, Sebastian Adeberg, Stefan A. Koerber, Jürgen Debus, Juliane Hörner‐Rieber	17
8	Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations 2022 ·Frontiers in Oncology ·Sebastian Regnery, (unknown), Fabian Weykamp, (unknown), Philipp Hoegen, Tanja Eichkorn, Thomas Held, Jonas Ristau, (unknown), Laila König, Michael Thomas, H. Winter, Sebastian Adeberg, Jürgen Debus, Sebastian Klüter, Juliane Hörner‐Rieber	25
9	SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes 2022 ·Radiotherapy and Oncology ·Sebastian Regnery, (unknown), (unknown), Fabian Weykamp, Thomas Held, Tanja Eichkorn, (unknown), (unknown), Sebastian Klüter, Jonas Ristau, Laila König, Stefan A. Koerber, Sebastian Adeberg, Jürgen Debus, Juliane Hörner‐Rieber	18
10	Detecting and Locating the Site of Local Relapse Using 18F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients—Potential Impact on PSMA-Guided Radiation Therapy 2022 ·Molecular Imaging and Biology ·Stefan A. Koerber, (unknown), Katharina Dendl, Clemens Kratochwil, Christine Fink, Jonas Ristau, (unknown), Klaus Herfarth, Gencay Hatiboglu, Markus Hohenfellner, Uwe Haberkorn, Jürgen Debus, Frederik L. Giesel	2
11	Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases 2022 ·Cancers ·Fabian Weykamp, (unknown), (unknown), Sebastian Regnery, Philipp Hoegen, Jonas Ristau, (unknown), Jakob Liermann, Tobias Förster, Kristin Lang, Laila König, (unknown), (unknown), Jürgen Debus, Sebastian Klüter, Juliane Hörner‐Rieber	14
12	FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Katharina Dendl, (unknown), Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Walter Mier, Jens Cardinale, Claudia Kesch, Manuel Röhrich, Hendrik Rathke, (unknown), Jonas Ristau, Sebastian Adeberg, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Stefan A. Koerber	48
13	Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity 2021 ·Radiation Oncology ·Jonas Ristau, M. Thiel, Sonja Katayama, Ingmar Schlampp, Kristin Lang, Matthias Häfner, Klaus Herfarth, Jürgen Debus, Stefan A. Koerber	12
14	Predicting the Risk of Metastases by PSMA-PET/CT—Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma 2021 ·Cancers ·Stefan A. Koerber, (unknown), Clemens Kratochwil, Ingmar Schlampp, Jonas Ristau, (unknown), (unknown), (unknown), Klaus Herfarth, Klaus Kopka, Tim Holland‐Letz, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Jürgen Debus, Frederik L. Giesel	9
15	Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer 2021 ·Cancers ·Jakob Liermann, Mustafa Syed, Edgar Ben‐Josef, Kai Schubert, Ingmar Schlampp, (unknown), Jonas Ristau, Fabian Weykamp, Manuel Röhrich, Stefan A. Koerber, Uwe Haberkorn, Jürgen Debus, Klaus Herfarth, Frederik L. Giesel, Patrick Naumann	37
16	Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective 2020 ·Frontiers in Oncology ·Jakob Liermann, Julia K. Winkler, Mustafa Syed, Ulf Neuberger, David Reuß, Semi Harrabi, Patrick Naumann, Jonas Ristau, Fabian Weykamp, Rami A. El Shafie, Laila König, Jürgen Debus, Jessica C. Hassel, Stefan Rieken	11
17	Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer 2020 ·Molecular Imaging and Biology ·Jonas Ristau, Frederik L. Giesel, Matthias F. Haefner, Fabian Staudinger, Thomas Lindner, Andreas Merkel, (unknown), Clemens Kratochwil, Peter L. Choyke, Klaus Herfarth, Jürgen Debus, Uwe Haberkorn, Stefan A. Koerber	32
18	EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK⁺ non‐small cell lung cancer 2018 ·International Journal of Cancer ·Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, (unknown), Martina Kirchner, Jonas Ristau, Ivo Buchhalter, Roland Penzel, Felix Herth, Claus Peter Heußel, Martin Eichhorn, Thomas Muley, Michael Meister, Jürgen R. Fischer, Stefan Rieken, Arne Warth, Helge Bischoff, Peter Schirmacher, Albrecht Stenzinger, Michael Thomas	79
19	Suitability of Circulating miRNAs as Potential Prognostic Markers in Colorectal Cancer 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Jonas Ristau, (unknown), Petra Schrotz‐King, Biljana Gigic, Karen W. Makar, Michael Hoffmeister, Hermann Brenner, Alexis Ulrich, Martin Schneider, Cornelia M. Ulrich, (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact